Berroca® Express

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.E.000237.01.17
Date of registration and renewal:20.01.2017
Dosage form: & nbspGranules in a sachet package with a mass of 1800 mg ± 5%.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp BAD-sources of multivitamins containing individual minerals and mineral complexes BAD-sources of vitamin-mineral complexes Supplements containing zinc, copper, manganese Supplements containing calcium and phosphorus Supplements containing potassium and magnesium
Composition: & nbspE967, E420, calcium carbonate, E421, magnesium oxide, ascorbic acid, caffeine, guarana extract, E330, E500, food aroma "Acerola", nicotinamide, zinc citrate, calcium pantothenate, food flavors (flavoring substances, maltodextrin, E1450 and E1520) , pyridoxine hydrochloride, food flavor mint (flavoring substances, dextrin, E414, E421), riboflavin, E955, thiamine mononitrate, E950, folic acid, biotin, cyanocobalamin.
Scope: & nbspFor realization to the population as a biologically active food additive - an additional source of vitamin B1, vitamin B2, nicotinamide, pantothenic acid, vitamin B6, biotin, folic acid, vitamin B12, vitamin C, magnesium, zinc, a source of caffeine containing calcium.
Suggested Usage: & nbspAdults take 1 sachet (soluble in the mouth granules) in the morning during meals.Duration of admission is 1 month.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding, increased nervous excitability, insomnia, arterial hypertension.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:24 months.
Storage conditions:Store in a place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:Expert conclusion of the Research Institute of Nutrition "NII Nutrition" № 72 / E-1314 / б-15 of 24.09.2015, the test report of LLC "Test center of medicines" Biotechnology "№ T16-02784 dated August 24, 2016.
Recipient:Bayer, AOBayer, AO Russia
Information update date: & nbsp14.02.2017
Instructions
Up